* Target Revenue FY26: Rs. 1,000 crores. * Target EBITDA Margin FY26: 18%-20%. * PEDA intermediate capacity expanding to 8,500 MT by Q2 FY26. * Formulation capacity augmented by 3,500 MT per annum. * Planned Capital Expenditure for FY26: Rs. 116 crores, including Rs. 64 crores for Shalvis Specialties (Hamirpur). * Expects
* **FY26 Revenue Target:** Rs. 1,000 crores. * **FY26 EBITDA Margin Target:** 18%-20%. * **PEDA Capacity:** Expanded to 6,000 MT, targeting 8,500 MT by Q2 FY26. * **Formulation Capacity:** Augmented by 3,500 MT per annum, currently fully utilized. * **FY26 Capital Expenditure:** Rs. 116 crores, primarily for capacity expansion and
* FY26 Revenue Target: ₹1,000 Crores * FY26 EBITDA Margin Target: 18%-20% * PEDA Capacity Expansion: To 8,500 MTPA by Q2 FY26 * Formulation Capacity Boost: 3,500 MTPA added * FY26 Capital Expenditure: ₹116 Crores * Hamirpur Plant Potential: ₹1,000-1,100 Crores Revenue (long-term) * New Product Pipeline: 5 launches planned for
* FY26 Revenue Guidance: Expecting 10-12% year-on-year growth, with a strong recovery and ramp-up in Q3 and Q4. * FY26 EBITDA Margin Guidance: Anticipated to be maintained around 9.5-10% on new projects. * Order Inflow Target (FY26): Aiming for INR10,000-INR12,000 crores, including roads, railways, power, and building segments. * Asset Monetization:
* FY'26 Revenue Growth Guidance: 10-12% increase. * Operating Margin Outlook: Expected to stabilize at 9.5-10% in coming quarters, driven by higher margins from new projects. * FY'26 Order Inflow Target: INR10,000 crores to INR12,000 crores. * Asset Monetization: Target completion of 5 BOT and 5 HAM
Here are the key highlights from Ashoka Buildcon's forward-looking guidance: * Expected FY'26 Revenue Growth: 10-12%, driven by a strong H2 turnaround. * Projected EBITDA Margin: Approximately 9.5-10% for new EPC projects. * FY'26 Order Inflow Target: INR10,000-12,000 crores, focusing on Roads, Railways, Power.
* Sales Outlook: Anticipated steady overall growth, with 5-6% year-on-year rental escalation expected across its terminal business. The Chemical division is set to maintain its strong upward trend. * Margin Outlook: Chemical division's profit before tax surged 223% in Q1 FY'26 due to efficiency gains. Rising JNPT lease
* Sales Outlook: Chemical division expected to continue steady growth, aiming for strategic partnerships for further growth. Overall rental growth of 5-6% for FY'26 with JNPT expected 4-5% annual escalation. * Margin Outlook: Improved cost effectiveness from plant upgradation and raw material procurement changes for Chemicals, driving profit before tax
* Outlook for Sales: Expects 5-6% year-over-year rental income growth for FY26; planning 30-50% increase in JNPT Liquid Storage Terminal (LST) capacity over time. Chemical division expected to maintain steady revenue growth. * Outlook for Margins: Chemical division's improved profitability (223% PBT growth in Q1 FY26) driven by operational efficiencies
* Sales Outlook: Targeting 20% CAGR for FY26; expects to achieve/surpass full year guidance with H2 FY26 revenue exceeding INR1,500 crores. * Margin Outlook: Full-year EBITDA guidance maintained at 16.5%-17.5%, expected to be achieved or bettered through optimization efforts. * Order Book & Inflows: Current order book over
Key Facts on Outlook: * Full-year revenue growth targeted at 20% Compound Annual Growth Rate (CAGR) for FY26. * EBITDA margin guidance maintained at 16.5% to 17.5% for the full financial year. * Order inflow target for FY26 is INR 4,000 to INR 4,500 crores. * Existing order book exceeds
* Full-year revenue growth target: 20% CAGR (circa INR 2880 Cr). * EBITDA margin guidance: 16.5% to 17.5% for FY26. * Order inflow target: INR 4,000-4,500 crores for FY26, with expectation to surpass. * Full-year Capex outlook: INR 75-80 crores. * Q1 FY26 revenue: INR 599 crores (impacted by monsoon/Eid)